Towards accessible gene therapy: in vivo base editing to cure Sickle Cell Disease

Towards accessible gene therapy: in vivo base editing to cure Sickle Cell Disease

From the Cancer Consortium Lieber Lab, Department of Laboratory Medicine and Pathology, University of Washington
Science SpotlightDecember 18, 2024